COMMUNIQUÉS West-GlobeNewswire

HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma
21/03/2025
— First and only EZH2 inhibitor approved by the NMPA — — HUTCHMED’s fourth product, and its first approval in hematological malignancies — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 21, 2025 (GLOBE NEWSWIRE [...]
SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results
21/03/2025
Q4 2024 revenues were $10.3 million , up 47% from Q4 2023. This was an all-time quarterly record for the Company. Full year 2024 revenues were $32.6 million, up 60% from full year 2023 revenues. This was an all-time [...]
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
21/03/2025
New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma Under Review with Prescription Drug User Fee Act (PDUFA) Action Date of August 18, 2025 Acquisition of Chimerix by [...]
Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure
21/03/2025
Trial to assess intensive care liver support system across 13 UK centers, led by UCL, Royal Free, Kings College and Queen Elizabeth Birmingham Rapid co-primary endpoints measured over 10 and 28 days; readout Q1 2027 [...]
Real People, Real Results: What Users Are Saying About Prime Biome
21/03/2025
ST. PETERSBURG, Fla., March 21, 2025 (GLOBE NEWSWIRE) -- Maintaining healthy skin often focuses on external care, but the Prime Biome supplement claims to rejuvenate skin from within. According to the manufacturers, [...]
NeuroQuiet Reviews (Is It Safe And Legit to Use?) Tinnitus Relief Ingredients, Side Effects, And Benefits!
21/03/2025
AURORA, Colo., March 21, 2025 (GLOBE NEWSWIRE) -- NeuroQuiet is intricately designed to promote optimal ear health and support auditory functions and overall ear wellness. Its formula enhances brain performance and [...]
SPINEWAY : Point sur la procédure judiciaire contre Strategos
21/03/2025
Communiqué de presse Ecully, le 21 mars 2025 – 8h45 SPINEWAY Point sur la procédure judiciaire contre Strategos Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne [...]
CARBIOS announces changes to its governance and reaffirms its strategic objectives
21/03/2025
The Board of Directors has appointed Isabelle PARIZE as its Chairwoman and Vincent KAMEL as Chief Executive Officer with immediate effect CARBIOS reaffirms its objective of building its PET biorecycling plant in [...]
CARBIOS annonce une évolution de sa Gouvernance et réaffirme ses objectifs stratégiques
21/03/2025
Le Conseil d’administration nomme Isabelle PARIZE en qualité de Présidente du Conseil d'administration et Vincent KAMEL en tant que Directeur général avec effet immédiat. CARBIOS réaffirme son objectif de construire son [...]
Prostadine Reviews: Is It Safe And Legit For Prostate Health? Ingredients, Benefits, And Side Effects!
21/03/2025
TALLMADGE, Ohio, March 21, 2025 (GLOBE NEWSWIRE) -- Prostadine is a healthy dietary drink designed to support prostate health naturally. It contains natural ingredients that work in harmony to remove the toxic buildup [...]
Prime Biome Reviews: A Comprehensive Review of the Revolutionary Skin and Gut Health Supplement
21/03/2025
ST. PETERSBURG, Fla., March 21, 2025 (GLOBE NEWSWIRE) -- Prime Biome constitutes a revolutionary probiotic supplement which offers simultaneous benefits to skin and gut health to enhance body wellness throughout both [...]
Lipozem Reviews (2025): Consumer Reports on Lipozem Weight Loss Formula
21/03/2025
LAKELAND, Fla., March 21, 2025 (GLOBE NEWSWIRE) -- Lipozem is reshaping the weight loss arena, which has long been saturated with countless diets, grueling exercise regimens, and expensive medications. Rather than [...]
UCB Convening Notice to the General Meeting of the Shareholders 2025
21/03/2025
CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders to the ordinary general meeting of the shareholders (the “ General Meeting ”) which will be held on Thursday, 24 [...]
UCB Convocation à l'Assemblée Générale des Actionnaires 2025
21/03/2025
CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES Le Conseil d’administration invite les actionnaires à l’assemblée générale ordinaire des actionnaires (« l’Assemblée Générale ») qui se tiendra le jeudi 24 avril 2025 [...]
Driven by its Pharmaceutical Activities, Roquette's 2024 Results Demonstrate the Resilience of its Integrated Business Model
21/03/2025
Driven by its Pharmaceutical Activities, Roquette's 2024 Results Demonstrate the Resilience of its Integrated Business Model Commercial performance in line with a market which remains below historical levels. 2024 [...]
Portés par ses activités pharmaceutiques, les résultats 2024 de Roquette démontrent la résilience de son modèle intégré
21/03/2025
Portés par ses activités pharmaceutiques, les résultats 2024 de Roquette démontrent la résilience de son modèle intégré Performances commerciales en ligne avec un marché qui reste en deçà des niveaux historiques. [...]
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
21/03/2025
Novartis receives third FDA approval for oral Fabhalta ® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Phase III study showed sustained proteinuria reduction at one year with favorable [...]
Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities
20/03/2025
ZUG, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to trades entered into by a PDMR of the Company pursuant to a 10b5-1 trading plan, in accordance with Rule 10b5-1(c)(1) of the [...]
vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
20/03/2025
Clinical hold lifted for late stage cadisegliatin program for diabetes CATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to resume Q2 2025 Strengthens commercial leadership with appointment of Martin [...]

Pages